Paradigm Diagnostics Announces the Addition of Industry Executive Mara Aspinall to the Board of Directors as Part of the Series B Extension Closing Totaling $15 Million paradigmdx.com/paradigm-diag…
Why wait when you can have your results in 5 business days? 🔬 🧬 MSI added to PCDx NGS Panel paradigmdx.com/msi-added-to-…
Paradigm retweeted
Congratulations to these 10 awardees in our Fall 2018 Arizona Innovation Challenge (AIC)! We're excited to help you grow in #Arizona @Bmetabolism @etracktech #MindsetMedical @Air2O @Paradigm_DX @TeamPersosa @quotecounters @QwickJobs @trainual @VirtuousCRM https://teapawt.net/t.co/elUStbMpzJ
We are delighted to introduce our new Facebook page called Better Cancer Answers designed to help consumers learn about genomic testing. Please join us there too and share the news!
facebook.com/bettercancerans…
Paradigm retweeted
Bioscience firms in #Arizona are making waves 🌊in the search for a #cancer treatment. We explain which companies have developed new #tech and drugs that could help discover and treat early cancer >>> @Paradigm_DX @VisionGate3D https://teapawt.net/t.co/Ks6QcDpUcL
Paradigm's PCDx test can obtain high quality NGS results from both small specimens & those with a low % of tumor in clinical settings
#PLOSONE: Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples ... dx.plos.org/10.1371/journal.…
Paradigm Announces Published Results Showing its Unique Ability to Get Comprehensive Actionable Results from Minimal Tumors paradigmdx.com/paradigm-anno…
facebook.com/paradigmdx/vide… Meet Dr. Glen Weiss - Paradigm Oncology Advisor.
Interesting insights about Cancer Genomic Profiling.
New Nature Paper just published demonstrating superior results in NSCLC of the ArcherDX, Inc. FusionPlex assay vs Am…lnkd.in/gvHGUQ3
2
Paradigm retweeted
treating cancer as a genetic disease, ignoring site of origin
nytimes.com/2017/06/08/healt…
Come visit @Paradigm_DX at #ASCO2017 booth #19161 to learn more about how we can provide CGP on small tumor specimens - in 4-5 business days
Paradigm retweeted
#PrecisionMedicine is Lengthening Survival Without Increasing Cost [9/27/16] Cowley ow.ly/mGZT305ZahN #hpeonc
Paradigm retweeted
National Rollout of Genomic Breast Cancer Registry with @Paradigm_DX @TMECouncil Launched prn.to/2qrVQ9k
Paradigm retweeted
The FDA approved the first new treatment in a decade for hepatocellular carcinoma. Learn more on the AACR blog: sm.aacr.org/45oR30blfkb











